NFYA and prostate carcinoma: Therefore, we decided to analyze the effect of NF-YA knock-down in PC3 prostate cancer cells derived from a bone metastasis that show features of highly aggressive small cell neuroendocrine carcinoma (SCNC), an aggressive histological subtype of CRPC (metastatic castration-resistant prostate cancer).